Unknown

Dataset Information

0

Time of administration important? Morning versus evening dosing of valsartan.


ABSTRACT: Studies suggest that bedtime dosing of an angiotensin-converting enzyme (ACE)-inhibitor or angiotensin receptor blocker shows a more sustained and consistent 24-h antihypertensive profile, including greater night-time blood pressure (BP) reduction. We compared the antihypertensive effects of morning (a.m.) and evening (p.m.) dosing of valsartan on 24-h BP.This 26-week, multicentre, randomized, double-blind study evaluated the efficacy and safety of valsartan 320?mg, dosed a.m. or p.m., versus lisinopril 40?mg (a.m.), a long-acting ACE-inhibitor, in patients with grade 1-2 hypertension and at least one additional cardiovascular risk factor. Patients (n?=?1093; BP?=?156?±?11/91?±?8?mmHg; 62 years, 56% male, 99% white) received (1?:?1?:?1) valsartan 160?mg a.m. or p.m. or lisinopril 20?mg a.m. for 4 weeks, then force-titrated to double the initial dose for 8 weeks. At Week 12, hydrochlorothiazide (HCTZ) 12.5?mg was added for 14 weeks if office BP was more than 140/90?mmHg and/or ambulatory BP more than 130/80?mmHg.Mean 24-h ambulatory SBP change from baseline to Weeks 12 and 26 was comparable between valsartan a.m. (-10.6 and -13.3?mmHg) and p.m. (-9.8 and -12.3?mmHg) and lisinopril (-10.7 and -13.7?mmHg). There was no benefit of valsartan p.m. versus a.m. on night-time BP, early morning BP and morning BP surge. Evening dosing also did not improve BP lowering in patients requiring add-on HCTZ or in nondippers at baseline. All treatments were well tolerated.Once-daily dosing of valsartan 320?mg results in equally effective 24-h BP efficacy, regardless of dosing time.ClinicalTrials.gov Identifier: NCT00241124.

SUBMITTER: Zappe DH 

PROVIDER: S-EPMC4284009 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Time of administration important? Morning versus evening dosing of valsartan.

Zappe Dion H DH   Crikelair Nora N   Kandra Albert A   Palatini Paolo P  

Journal of hypertension 20150201 2


<h4>Objective</h4>Studies suggest that bedtime dosing of an angiotensin-converting enzyme (ACE)-inhibitor or angiotensin receptor blocker shows a more sustained and consistent 24-h antihypertensive profile, including greater night-time blood pressure (BP) reduction. We compared the antihypertensive effects of morning (a.m.) and evening (p.m.) dosing of valsartan on 24-h BP.<h4>Methods</h4>This 26-week, multicentre, randomized, double-blind study evaluated the efficacy and safety of valsartan 320  ...[more]

Similar Datasets

| S-EPMC9040377 | biostudies-literature
| S-EPMC6918562 | biostudies-literature
| S-EPMC9631239 | biostudies-literature
| S-EPMC8744932 | biostudies-literature
| S-EPMC4173928 | biostudies-literature
| S-EPMC4989998 | biostudies-literature
| S-EPMC8167502 | biostudies-literature
| S-EPMC5869278 | biostudies-literature
| S-EPMC9832518 | biostudies-literature
| S-EPMC8766290 | biostudies-literature